Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04766151
Other study ID # 27
Secondary ID
Status Recruiting
Phase Phase 3
First received
Last updated
Start date January 1, 2021
Est. completion date June 30, 2022

Study information

Verified date February 2021
Source 424 General Military Hospital
Contact Fotios Oikonomou, MD, PhD
Phone 00306977618318
Email economouf@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Transradial cardiac catheterization and percutaneous coronary intervention are increasingly being performed worldwide in elective and emergency procedures, with many centres adopting the transradial route as their first choice of arterial access. One of the most common complications encountered during transradial procedures is radial artery spasm. The aim of this study is to evaluate the Efficacy and Safety of the use of transdermal Glyceryl trinitrate patches applied to skin before cardiac catheterization to prevent the occurrence of radial artery spasm during transradial access cardiac catheterization.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date June 30, 2022
Est. primary completion date December 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Male or female 18 -85 years old who has been admitted for scheduled coronary angiography by radial artery Exclusion Criteria: - Prior same radial artery catheterization - Positive Allen test - Severe Hypotension (SBP<100 mmHg) - Pregnancy - Ongoing Acute Myocardial Infarction - Ongoing cardiogenic shock - Known History of Nitrates intolerance/allergy

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Transdermal glyceryl trinitrate 10mg patches
Transdermal patches applied to skin 30 minutes before cardiac catheterization
Placebo patches
Transdermal placebo patches applied to skin 30 minutes before cardiac catheterization

Locations

Country Name City State
Greece 424 GeneralMH Thessaloniki

Sponsors (2)

Lead Sponsor Collaborator
424 General Military Hospital Aristotle University Of Thessaloniki

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Radial Spasm occurrence Radial spasm is measured by the exerting force (in Newton) removing the sheath from the patient Immediately after the end of the procedure
Primary Successful radial puncture The success is defined by the fast radial puncture and catheterization and is measured by the time of radial catheterization During radial puncture and catheterization
Secondary VRS-4 pain scale The pain during the procedure is measured by the four-category verbal rating scale (VRS-4) During the whole procedure
Secondary State-Trait Anxiety Inventory (STAI) The anxiety during the procedure is measured by the State - Trait Anxiety Inventory (STAI) During the whole procedure
See also
  Status Clinical Trial Phase
Completed NCT02832115 - Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention Phase 4
Recruiting NCT05861765 - The Efficacy of Papaverine to Prevent Radial Artery Spasm During Transradial Cerebral Angiography Phase 2
Recruiting NCT06447688 - Does Verapamil Given Orally Prevent Radial Artery Spasm During Transradial Coronary Angiography Phase 4
Recruiting NCT03501212 - Effect of Topical Anesthesia on Patient's Pain Discomfort and Radial Artery Spasm in Transradial Catheterization Phase 4